Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats
Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats
复制标题
氟非尼酮减弱缺氧诱导的大鼠肺动脉高压的血管重塑。
DOI:
10.1139/cjpp-2013-0056
复制
发表时间:
2014-01-01
影响因子:
2.1
通讯作者:
Li, Xiao-Hui
中科院分区:
文献类型:
--
作者:
Li, Xian-Wei;Du, Jie;Li, Xiao-Hui
Fluorofenidone (AKF-PD) is a novel pyridone derivate that targets transforming growth factor-beta(1) (TGF-beta(1)) signaling. Previous studies have proven that AKF-PD functions as an antifibrotic agent in pulmonary fibrosis and renal fibrosis models. Activated TGF-beta(1) signaling is thought to be a major feature of pulmonary hypertension (PH). TGF-beta(1) exerts powerful pro-proliferation effects on pulmonary arterial smooth muscle cells (PASMCs), and hence, prompts vascular remodeling. This study is designed to investigate the effect of AKF-PD on vascular remodeling in a rat model of hypoxia-induced PH. PH was induced in rats by 4 weeks of hypoxia. The expression of TGF-beta(1), collagen I, and collagen III was analyzed by ELISA, immunohistochemistry, real-time PCR, or Western blot. Proliferation of cultured PASMCs was determined by the BrdU incorporation method and flow cytometry. The results showed that AKF-PD treatment (0.5 or 1.0 g.(kg body mass).d(-1)) for 4 weeks attenuated pulmonary vascular remodeling and improved homodynamic parameters. TGF-beta(1) level was significantly down-regulated by AKF-PD both in vivo and in vitro. Furthermore, hypoxia-and TGF-beta(1)-induced PASMC proliferation and collagen expression were both significantly suppressed by AKF-PD. These results suggest that AKF-PD ameliorates the progression of PH induced by hypoxia in rats through its regulation of TGF-beta(1) expression, PASMC proliferation, and the extracellular matrix.